Table 3.
Creatine kinase (CK) at pre- and 4, 48, and 96 h postexercise, maximal voluntary isometric contraction (MVC) torque, range of motion (ROM), circumference (CIR), and muscle soreness (SOR) at pre-; immediately post-; and 4, 48, and 96 h postexercise.
| E-FP | M-LP | |
|---|---|---|
| CK activity (U/L) | ||
| Pre | 79.5 (54.5–89.3) | 64.5 (56.0–81.3) |
| 4 h | 82.0 (62.0–90.3) | 76.5 (58.5–87.8) |
| 48 h | 314.0 (102.5–649.3) | 199.0 (78.3–1496.0) |
| 96 h | 3997.5 (228.6–7712.3) | 5893.5 (216.3–10,195.3) |
| MVC torque (Nm) | ||
| Pre | 29.2 (27.2–31.4) | 29.0 (25.0–33.0) |
| IP | 17.4 (10.1–18.0) | 11.8 (8.6–14.2) |
| 4 h | 17.3 (13.5–19.8) | 15.7 (14.2–21.2) |
| 48 h | 17.2 (16.6–21.4) | 17.0 (15.5–22.2) |
| 96 h | 20.2 (17.3–25.9) | 19.0 (16.7–23.9) |
| ROM (°) | ||
| Pre | 151.5 (145.6–158.1) | 148.1 (140.9–151.1) |
| IP | 126.8 (115.5–139.1) | 126.8 (119.7–129.0) |
| 4 h | 132.5 (130.8–140.4) | 129.5 (124.5–136.6) |
| 48 h | 137.5 (123.8–142.5) | 129.8 (118.1–135.0) |
| 96 h | 138.8 (132.8–146.8) | 134.6 (125.9–139.9) |
| CIR (cm) | ||
| Pre | 28.7 (25.1–29.6) | 27.4 (24.7–32.1) |
| IP | 28.9 (25.4–29.8) | 27.4 (24.9–32.3) |
| 4 h | 28.6 (25.5–29.7) | 27.2 (25.0–32.2) |
| 48 h | 28.8 (25.8–29.5) | 27.6 (24.9–32.4) |
| 96 h | 28.9 (25.8–29.8) | 27.8 (24.9–32.6) |
| SOR (mm) | ||
| Pre | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| IP | 3.5 (0.0–14.5) | 13.0 (0.5–26.5) |
| 4 h | 0.5 (0.0–3.5) | 9.5 (1.0–14.9) |
| 48 h | 34.5 (10.3–61.3) | 45.5 (29.0–72.0) |
| 96 h | 21.0 (5.5–52.3) | 34.5 (11.5–55.3) |
Data are expressed as median (interquartile range); E-FP, early follicular phase group; M-LP, mid-luteal phase group; Pre, pre-exercise; IP, immediately post exercise. A main effect for time was observed for all markers.